Who
Arjun J.J. Desai
Director
Company insider
Files Form 4 as: Director, Longeveron; Director, Clene; Director, TriSalus Life Sciences.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $111K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 10 Aug 2023
- Last trade
- 19 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,674 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,674 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,158 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,158 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,168 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,168 at $0.00 | filing |
| 13 Nov 2025filed 14 Nov 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,177 at $0.00 | filing |
| 14 Aug 2025filed 15 Aug 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,278 at $0.00 | filing |
| 12 Jun 2025filed 27 Jun 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,021 at $0.00 | filing |
| 27 Feb 2025filed 28 Feb 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,319 at $0.00 | filing |
| 10 Dec 2024filed 12 Dec 2024 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $111K30,000 at $3.69 | filing |
| 6 Dec 2024filed 9 Dec 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,280 at $0.00 | filing |
| 2 Oct 2024filed 3 Oct 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,943 at $0.00 | filing |
| 13 Aug 2024filed 21 Aug 2024 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
Reviewing TriSalus Life Sciences (NASDAQ:TLSI) and Brainsway (NASDAQ:BWAY)TLSI · themarketsdaily.com · 21 Oct 2026Financial Comparison: Brainsway (NASDAQ:BWAY) and TriSalus Life Sciences (NASDAQ:TLSI)TLSI · dailypolitical.com · 14 Oct 2026TriSalus Life Sciences, Inc. (TLSI) – What Are Brokerages Saying About This Stock?TLSI · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Arjun J.J. Desai; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.